Approval of Enzalutamide for the Treatment of Prostate Cancer in Japan
The Japan Ministry of Health, Labour and Welfare (MHLW) approves the use of XTANDI® (enzalutamide) by Astellas Pharma Inc., for the treatment of prostate cancer with distant metastasis. XTANDI®...